ArticleJournal of clinical medicine2024

Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine.

Emmanouil V Dermitzakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.